A Critical Review on Therapeutic Imaging in Oncology

Keyan Miao

doi:10.54254/2753-8818/2025.24475

Theoretical and Natural ScienceOpen access

A Critical Review on Therapeutic Imaging in Oncology

Research Article

Open Access

A Critical Review on Therapeutic Imaging in Oncology

Keyan Miao ^1*

¹ Wuhan Institute of Bioengineering, Wuhan University of Bioengineering, Wuhan, China

^*Corresponding author: 2878361539@qq.com

Published on 4 July 2025

TNS Vol.123

ISSN (Print): 2753-8826

ISSN (Online): 2753-8818

ISBN (Print): 978-1-80590-187-7

ISBN (Online): 978-1-80590-188-4

Download Cover

Abstract

Oncology, a critical discipline within medical science, is dedicated to understanding the mechanisms of tumor development, progression, diagnosis, and treatment. As medical technologies advance, cancer therapies have diversified to include surgical resection, radiotherapy, chemotherapy, and more recently, immunotherapy. However, challenges persist—particularly in accurately locating tumor tissues, monitoring treatment efficacy in real time, and minimizing treatment-related side effects. Therapeutic imaging technologies have emerged as essential tools to address these challenges, enhancing the precision and adaptability of oncological care. By providing detailed visualization of tumor structure and function, these technologies support accurate diagnosis, guide therapeutic interventions, and enable dynamic treatment evaluation. Recent innovations—such as multimodal imaging, artificial intelligence-driven diagnostics, and molecular-targeted approaches—have significantly expanded the capabilities of therapeutic imaging. Technologies like dynamic full-field optical coherence tomography (D-FFOCT), microscopic optical tomography (MOST/fMOST), and near-infrared fluorescent probes demonstrate the growing role of intelligent imaging in surgical navigation, pathology mapping, and phototherapy. Meanwhile, the integration of modalities such as photoacoustic imaging, MRI, and PET improves early-stage tumor detection and therapeutic monitoring. Emerging strategies, including nanoparticle self-assembly and multifunctional molecular probes, are advancing the convergence of diagnostics and therapy. This review aims to provide a comprehensive overview of therapeutic imaging in oncology, examining its theoretical foundations, clinical applications, and future development trends.

Keywords:

Therapeutic Imaging, Oncology, Multimodal Imaging

View PDF

References

[1]. He P, Tang H, Zheng Y, Xu X, Peng X, Jiang T, Xiong Y, Zhang Y, Zhang Y, Liu G. Optical molecular imaging technology and its application in precise surgical navigation of liver cancer. Theranostics. 2025 Jan 1;15(3):1017-1034. doi: 10. 7150/thno. 102671. PMID: 39776802; PMCID: PMC11700863.

[2]. Scholler J, Groux K, Goureau O, Sahel JA, Fink M, Reichman S, Boccara C, Grieve K. Dynamic full-field optical coherence tomography: 3D live-imaging of retinal organoids. Light Sci Appl. 2020 Aug 17;9:140. doi: 10. 1038/s41377-020-00375-8. PMID: 32864115; PMCID: PMC7429964.

[3]. Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ. MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics. 2019 Mar-Apr;39(2):367-387. doi: 10. 1148/rg. 2019180114. Epub 2019 Feb 15. PMID: 30768361; PMCID: PMC6438362.

[4]. Yan J, Wang C, Jiang X, Wei Y, Wang Q, Cui K, Xu X, Wang F, Zhang L. Application of phototherapy-based nanoparticles in colorectal cancer. Int J Biol Sci. April 2, 2021; 17e (5): 1361-1381. Doi: 10. 7150/ijbs. 58773. PMID: 33867852; PMCID: PMC8040477.

[5]. Singh Y, Hathaway QA, Erickson BJ. Generative AI in oncological imaging: Revolutionizing cancer detection and diagnosis. Oncotarget. 2024 Sep 4;15:607-608. doi: 10. 18632/oncotarget. 28640. PMID: 39236061; PMCID: PMC11376594.

[6]. Shimizu H, Nakayama KI. Artificial intelligence in oncology. Cancer Sci. 2020 May;111(5):1452-1460. doi: 10. 1111/cas. 14377. Epub 2020 Mar 21. PMID: 32133724; PMCID: PMC7226189.

[7]. Belge Bilgin G, Bilgin C, Burkett BJ, Orme JJ, Childs DS, Thorpe MP, Halfdanarson TR, Johnson GB, Kendi AT, Sartor O. Theranostics and artificial intelligence: new frontiers in personalized medicine. Theranostics. 2024 Mar 25;14(6):2367-2378. doi: 10. 7150/thno. 94788. PMID: 38646652; PMCID: PMC11024845.

References

[6]. Shimizu H, Nakayama KI. Artificial intelligence in oncology. Cancer Sci. 2020 May;111(5):1452-1460. doi: 10. 1111/cas. 14377. Epub 2020 Mar 21. PMID: 32133724; PMCID: PMC7226189.

Cite this article

Miao,K. (2025). A Critical Review on Therapeutic Imaging in Oncology. Theoretical and Natural Science,123,7-12.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

About volume

Volume title: Proceedings of the 5th International Conference on Biological Engineering and Medical Science

ISBN: 978-1-80590-187-7(Print) / 978-1-80590-188-4(Online)

Editor: Alan Wang

Conference website: https://2025.icbiomed.org/

Conference date: 24 October 2025

Series: Theoretical and Natural Science

Volume number: Vol.123

ISSN: 2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:

1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).